Here are relevant reports on : european-storage
-
European Food Safety Testing Market By Contaminant (Pathogen, GMO, Toxin, Pesticide), Technology (Traditional & Rapid), Food Type (Meat & Poultry Product, Dairy Product, Fruit & Vegetable, Processed Food) & Country - Trends & Forecast To 2018
Increasing outbreak of foodborne illnesses and poisoning risks in Europe has resulted European Food Safety Authority (EFSA) to impose strict food safety regulations. The food safety regulations specify maximum permitted level of any contaminant in food. EFSA has also specified that all the food manufacturers are responsible for safety of food. So, food safety testing has to be implemented during all the stage of food production to ensure absence of contaminations and prevent any potential health risks upon consumption of contaminated food. The regulatory bodies in Europe have been implementing Hazard Analysis Critical Control Point (HACCP) systems to ensure food safety. Implementation of these food safety regulations has been driving the food safety testing market. Globalization of food supply and demand of the consumer for food safety and information has further helped the market to grow.
- Published: July 2013
- Price: $ 4950
- TOC Available:
-
European Smart Home Market by Lighting Controls, Smart Speakers, Entertainment Controls, HVAC Controls, Security & Access Control, Smart Kitchen, Home Healthcare, Smart Furniture, Home Appliances, Wired, Behavioral, Proactive - Global Forecast to 2030
The European smart home market is expected to grow from USD 24.74 billion in 2025 to USD 36.12 billion by 2030, at a compound annual growth rate (CAGR) of 7.9% during the forecast period. The Key Players Johnson Controls Inc. (Ireland), Honeywell International Inc. (US), Schneider Electric (France), Siemens (Germany), ASSA ABLOY (Sweden), Amazon.com, Inc. (US), Apple Inc. (US), Resideo Technologies Inc. (US), Robert Bosch (Germany), and ABB (Switzerland).
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
European Microscopy Market by Product (Optical (Fluorescence, Super-Resolution), Confocal, Electron (Transmission), Scanning (AFM)), Application (Semiconductor, Life Science, Nanotechnology), End User (Academic Institute, Industries) - Forecast to 2020
The European microscopy market is estimated to grow at a CAGR of 7.0% to reach $ 1,798.4 Million by 2020. Optical microscopy is the largest segment of the microscopy market. The electron microscopes product segment is expected to show the fastest growth during the forecast period. Key players operating in the microscopy market are Carl Zeiss (Germany), FEI Co. (U.S.), Leica Microsystems (Danaher Corp.) (U.K.) and Nikon Corporation (Japan).
- Published: May 2015
- Price: $ 4950
- TOC Available:
-
European Infection Control Market by Product (Sterilization Equipment (Hydrogen Peroxide, Ethylene) Indicators), Service (ETO, Gamma), Disinfectants (Wipes, Sprays), Gown, Drapes, Endoscope Reprocessing, End User (Hospitals, Pharma) - Forecast to 2030
The global European infection control market, valued at US$14.14 billion in 2024, stood at US$14.99 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2025 to 2030, culminating in a forecasted valuation of US$20.58 billion by the end of the period. The growth of the European infection control market in Germany is strongly supported by the high infectious disease burden, increasing awareness on early disease diagnosis, and expanding public health initiatives and infection control programs.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
European Healthcare EDI Market by Supplier (Distributors and Wholesalers, GPOS, Manufacturers), Purchasing Organization (Hospitals, GPOS), Transaction (Orders, Ordersp, Desadv, Recadv, Invoic), Transaction Types and Its Penetration
The effective use of electronic data interchange (EDI) is the key to better healthcare supply chain management. In healthcare supply chain management (SCM), EDI primarily focuses on the electronic exchange of business transactions such as purchase orders, shipment authorizations, shipment acknowledgements, advanced shipment notices, or invoices. EDI provides a fast, secure, and easy exchange of information between healthcare organizations.
- Published: July 2016
- Price: $ 4950
- TOC Available:
-
European Mammography Workstations Market by Modality (Multimodal, Standalone), Application (Diagnosis, Advanced Imaging, Clinical Review), End User (Hospital, Breast Care Centers, Academia), Country (Germany, UK, France, Italy, Spain) - Forecast to 2024
The European mammography workstations market is estimated to grow at a CAGR of 5.5% to reach USD 14 million by 2024 from USD 10 million in 2018. Factors such as the rising burden of breast cancer, increasing market availability of multimodality diagnostic platforms, and the increasing patient awareness about the clinical benefits associated with the early diagnosis of breast conditions are driving the growth of the European mammography workstations market.General Electric (US), Koninklijke Philips N.V. (Netherlands), Hologic Inc. (US), Siemens (Germany), and FUJIFILM Corporation (Japan) are the major players in the European mammography workstations market. Other prominent players in this market include Carestream Health (US), EIZO Corporation (Japan), Agfa-Gevaert Group (Belgium), Barco (Belgium), Konica Minolta, Inc. (Japan), Benetec Advanced Medical Systems (Belgium), PLANMED OY (Finland), Sectra AB (Sweden), Aycan Medical Systems, LLC. (US), and Esaote SPA (Italy).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
European Hemostats & Sealants Market by Brand (Hemopatch [Baxter], Tachosil [Takeda], Veriset [Medtronic], Avitene [C.R Bard], Sangustop [B Braun], Lyostypt [B Braun]), Country (Germany, Uk, France, Italy & Spain) - Forecast to 2024
The European hemostats and sealants market is projected to reach USD 89 million by 2024 from USD 63 million in 2019, at a CAGR of 7.0%. The growth of this market is majorly driven by the launch of new products and favorable reimbursement scenario. However, the shift toward minimally invasive surgeries and adverse effect of hemostats are the major factors restraining the growth of this market. B. Braun (Germany), Medtronic (Ireland), C. R. Bard (US), Takeda (Japan), and Baxter (US).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
European Paints and Coatings Market by Resin Type (Acrylic, Alkyd, Epoxy, Polyester, PU, Fluoropolymer, Vinyl), Technology (Waterborne, Solvent borne, Powder), End-use (Architectural and Industrial), and Country - Global Forecast to 2028
The european paints and coatings market is expected to grow from USD 37.2 billion in 2023 to USD 41.6 billion by 2028, at a CAGR of 2.3% during the forecast period. The key players profiled in the European Paints and Coatings market report are Akzo Nobel NV (Netherlands), PPG Industries, Inc. (US), The Sherwin-Williams Company (US), BASF Coatings GmbH (Germany), Jotun A/S (Norway), and Axalta Coating Systems LLC (US).
- Published: May 2023
- Price: $ 4950
- TOC Available:
-
European Medical Devices Market by Type (Diagnostic Imaging, Endoscopy Equipment, Respiratory Care, Cardiac Monitoring Devices, Haemodialysis Devices, Ophthalmic Devices, Anesthesia Monitoring), End User (Hospitals, Home-care) & Region - Global Forecast to 2025
European medical devices market growth is primed to transition from $48.9 billion in 2020 to $61.4 billion by 2025, showcasing a strong CAGR of 4.7%. Key growth drivers include an aging population, advancements in medical technology, and an increasing number of surgical procedures, alongside the need for cost containment in healthcare.
- Published: May 2020
- Price: $ 4950
- TOC Available:
-
European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020
The NGS services market in Europe is expected to reach USD 1,152 Million by 2020 from USD 444 Million in 2015, at a CAGR of 21% from 2015 to 2020. Factors such as rising preference of NGS over other platforms; rapid and cost-efficient sequencing; rising prevalence of inherited diseases; application of genomics in drug discovery; growing prevalence of cancer and other malignant diseases; and partnerships among companies, R&D centers, and universities are expected to drive market growth. However, high dependence on grants for R&D, lack of analytics, and stringent reimbursement policies are likely to restrict the growth of this market to a certain extent.
- Published: October 2015
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
